Oprozomib
Oprozomib (ONX-0912; PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
Product Specifications
CAS Number
935888-69-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.6092
Molecular Formula
C25H32N4O7S
Notes
Research use only, not for human use.
Receptor
20Sproteasome
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2169355-01 0.1 mL
FITC-Linked Monoclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Ask
View Details MBS2169355-02 0.2 mL
FITC-Linked Monoclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Ask
View Details 
MBS2169355-03 0.5 mL
FITC-Linked Monoclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Ask
View Details MBS2169355-04 1 mL
FITC-Linked Monoclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Ask
View Details MBS2169355-05 5 mL
FITC-Linked Monoclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Ask
View Details MBS2169355-06 5x 5 mL
FITC-Linked Monoclonal Antibody to HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Ask
View Details